Position in NSRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,440
-$13,860 QoQ
Shares Held
2,000
0.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 9 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NSRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $57,054,147,722 across 20 Drug Manufacturers - General names. NSRX ranks #19 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,437,458 | $14,198,910,733 | |
| 2 | JNJ |
Johnson & Johnson
|
44,721,167 | $10,931,642,052 | |
| 3 | ABBV |
AbbVie Inc.
|
38,016,774 | $8,268,268,167 | |
| 4 | MRK |
Merck & Co., Inc.
|
47,632,487 | $5,729,711,852 | |
| 5 | AMGN |
Amgen Inc
|
15,836,058 | $5,571,916,998 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
23,299,295 | $3,247,222,731 | |
| 7 | PFE |
Pfizer Inc
|
92,685,370 | $2,602,605,180 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,198,554 | $1,770,892,290 |
All Filings in NSRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,440 | 2,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $18,300 | 2,000 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $13,300 | 2,000 | Shares | Defined | 2026-05-27 | |
| No filing history on record for this holder in this stock. | ||||||